通过LRRK2-GSDMD轴介导的肠道炎症,LRRK2 G2019S可能促进结肠癌
Yuhang Wang1, Joyce Z Gao1, Taylor Sakaguchi1
1Department of Pathology, University of Iowa, Iowa City, IA 52242, USA.
Cells
|April 12, 2024
概括
该LRRK2 G2019S突变通过增加炎症和细胞增殖促进结肠癌. 抑制LRRK2激酶活性可降低小鼠模型中的瘤生长和严重程度.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
背景情况:
- 氨酸丰富的重复激酶2 (LRRK2) 是一种氨酸-氨酸激酶.
- LRRK2 G2019S突变与帕金森病和癌症风险增加有关.
- 连接LRRK2 G2019S与结肠癌的机制尚不清楚.
研究的目的:
- 研究LRRK2 G2019S在结肠癌发展中的作用.
- 阐明LRRK2 G2019S影响结直肠瘤发生的分子机制.
主要方法:
- 使用大肠炎相关癌症 (CAC) 鼠标模型.
- 使用的LRRK2 G2019S敲进 (KI) 鼠标模型.
- 施用硫酸 (DSS) 诱导大肠炎.
- 评估瘤发育,炎症,细胞增殖和炎症酶激活.
- 测试了LRRK2激酶抑制剂和GSDMD抑制剂的疗效.
主要成果:
- 在KI小鼠中,LRRK2 G2019S显著增加了瘤的数量和大小.
- LRRK2 G2019S增强了肠上皮细胞的增殖和炎症.
- KI小鼠对DSS诱导的大肠炎的易感性增加.
- LRRK2 G2019S促进了炎症酶激活和肠道上皮的死亡.
- 抑制LRRK2激酶活性和GSDMD减弱性结肠炎和CAC进展.
结论:
- 在LRRK2中获得酶活性促进结直肠瘤发生.
- LRRK2 G2019S会加剧结肠中的炎症和细胞死亡.
- LRRK2代表了结肠癌患者的潜在治疗标,其激酶活性升高.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.9K
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
883
相关概念视频
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...